Results 151 to 160 of about 7,148 (201)
Some of the next articles are maybe not open access.

Medication overuse headache

Current Opinion in Neurology, 2021
Purpose of review Medication overuse headache (MOH)is a disabling problem worldwide with areas of controversy regarding its cause. This article reviews the recent ideas regarding the development of this disorder and its effective management. Recent findings It has been proposed that
Girish Baburao, Kulkarni   +2 more
openaire   +4 more sources

Medication Overuse Headache

Headache: The Journal of Head and Face Pain, 2014
Background Medication overuse headache ( MOH ) affects between 1% and 2% of the general population but is present in up to 50% of patients seen in headache centers. There are currently no internationally accepted guidelines for treatment of
Munksgaard, Signe B, Jensen, Rigmor H
openaire   +5 more sources

Medication overuse headache

Current Treatment Options in Neurology, 2001
Medication overuse headache is common and affects 2% of the United States population. Simple analgesics, caffeine-containing analgesics, butalbital-containing analgesics, opioids, ergotamine, and triptans may cause medication overuse headache. The recidivism rate is higher after detoxification from butalbital and opioids than after detoxification from ...
H C, Diener, Z, Katsarava
openaire   +4 more sources

Medication overuse headache

Nature Reviews Disease Primers, 2023
Medication overuse headache (MOH) is a secondary headache disorder attributed to overuse of acute headache medications by a person with an underlying headache disorder, usually migraine or tension-type headache. MOH is common among individuals with 15 or more headache days per month. Although MOH is associated with substantial disability and reductions
Sait Ashina   +9 more
openaire   +4 more sources

Medication-overuse headache

Current Opinion in Neurology, 2013
Medication-overuse headache (MOH) is a well described clinical entity. There is a growing body of knowledge on the epidemiology of MOH, risk factors, and treatment strategies.The International Headache Society updated the classification criteria for MOH.
Katsarava, Zaza, Obermann, Mark
openaire   +3 more sources

Medication-overuse headache

Current Pain and Headache Reports, 2005
Medication-overuse headache (MOH) can be caused by almost all anti-headache drugs including analgesics, ergots, triptans, and combined preparations The prevalence of chronic daily headache (CDH) appears to be between 2% and 4% in the general population. Current epidemiologic studies suggest that MOH accounts for approximately 50% of these cases.
Lutz, Pageler   +2 more
openaire   +4 more sources

Medication overuse headache

Current Opinion in Neurology, 2004
The current literature on medication overuse headache will be reviewed with regard to clinical presentation, pathophysiology, therapy and prognosis in the light of the new headache classification.Medication overuse headache is a widely unrecognized medical condition, which according to recent epidemiological studies has evolved to the third most ...
Volker, Limmroth, Zaza, Katsarava
openaire   +4 more sources

Medication overuse headache

Current Neurology and Neuroscience Reports, 2009
The term medication overuse headache (MOH) was recently introduced by the International Headache Society to describe daily or nearly daily (chronic) headache that occurs after the regular intake (overuse) of any kind of antiheadache or antimigraine drug. Chronic headache is a growing problem throughout the world.
Zaza, Katsarava   +2 more
openaire   +2 more sources

Medication Overuse Headache

Headache: The Journal of Head and Face Pain, 2012
Medication-overuse headache (MOH) is a chronic daily headache in which acute medications used at high frequency cause transformation to headache occurring 15 or more days per month for 4 or more hours per day if left untreated. MOH is a form of US Food and Drug Administration-defined chronic migraine. This review will describe (1) MOH clinical features
openaire   +3 more sources

Medication Overuse Headaches

Medical Clinics of North America, 2013
“An ounce of prevention is worth a pound of cure” in the management of MOH. Prevention of transformation of primary headache types to their chronic counterparts is necessary to prevent this most troubling transformation. Strict attention to what patients are telling you (and often times not telling you) about their episodic headaches will enable ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy